Picture this: you feel a headache coming on and you’ve got to go to work/meet your friends/head out for dinner with your boyfriend, so what do you do? Naturally you reach straight for some painkillers and, if stats are to be relied upon, you’re more than likely going to take Nurofen – one of the biggest selling painkillers in the UK. However, it looks like we’re all being duped by the pharmaceutical giant, as an Australian watchdog has uncovered.
A court down under has ordered British corporation Reckitt Benckiser – the manufacturer of Nurofen – to remove some of the brands products from the shop floor after it was discovered that a range specifically designed to target individual sources of pain. Why you ask? Because it happened to be made from the EXACT same ingredients as Nurofen’s basic painkiller capsules but is retailed at a way higher price. Sneaky, huh?
Nurofen currently markets a ‘Specific Pain’ range, including Nurofen Back Pain, Nurofen Period Pain, Nurofen Migraine Pain and Nurofen Tension Headache, but the Australian Competition & Consumer Commission (ACCC) have said that the range is actually made up of the exact same active components–342mg of ibuprofen lysine, in case you’re wondering –despite costing almost double the price of their standard product.
After the ACCC highlighted the issue, the UK’s very own retail watchdog has weighed in on the mark-up debate, accusing the brand of false advertising, and could potentially follow in Australia’s banning footsteps. NOT want we need to here on the run up to all those Christmas parties and the inevitable heavy drinking that’s sure to ensue.
Run of the mill aspirin it is, then.